TABLE 3.
Clinical features | Recommended animal model methods | Recommended animal model outcome measures (expected endpoints) | |
---|---|---|---|
6 | Periodic limb movements: the presence of PLMS or PLMW at rates or intensity greater than expected for age or medical/medication status | Video-PSG | • Increase in number of TA EMG bursts/h during wakefulness or sleep as a function of their decreased inter-movement interval |
7 | Sleep disturbance (reduction in total sleep time, long sleep latency, more frequent sleep state transitions/fragmented sleep) | Activity monitoring | • Decrease in time spent at rest during the light period (decrease) • Increased transitions/h from activity to sustained rest and vice versa |
Activity monitoring after sleep deprivation | • Increased latency to sustained rest | ||
Video-PSG | • Decreased total sleep time during the light period • Decreased sleep bout length • Increase in transitions/h between different wake-sleep states |
||
Video-PSG after sleep deprivation | • Increased sleep latency |
PLMS, presence of periodic leg movements in sleep; PLMW, presence of periodic leg movements in resting wake; PSG, polysomnography; TA, tibialis anterior; EMG, electromyography.